Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Cancer
|
February 15, 1994
Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy
I Tepler, G Schwartz, K Parker, et al.
The Journal of Infectious Diseases
|
December 1, 1978
The natural history of recurrent facial-oral infection with herpes simplex virus
C Bader, C S Crumpacker, L E Schnipper, et al.
Journal of Virology
|
May 1, 1973
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VI. Characterization of the DNA from five nondefective hybrid viruses
P H Henry, L E Schnipper, R J Samaha, et al.
Science (New York, N.Y.)
|
August 31, 1979
Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo
I D Goldberg, M B Stemerman, L E Schnipper, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1994
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age
K Antman, L Ayash, A Elias, et al.
Bone Marrow Transplantation
|
July 1, 1992
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens
M V Seiden, A Elias, L Ayash, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1984
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir
S L Spruance, C S Crumpacker, L E Schnipper, et al.
Journal of Virology
|
December 1, 1976
Content and expression of integrated viral DNA in hamster cells transformed by nondefective adenovirus type 2- simian virus 40 hybrid viruses
J H Breeden, Y Wewerka-Lutz, L E Schnipper, et al.
Cancer Research
|
December 15, 1995
DNA topoisomerase II alpha expression is associated with alkylating agent resistance
J P Eder, V T Chan, S W Ng, et al.
Cancer Research
|
September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy
J P Eder, R C Bast, W P Peters, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Cancer
|
February 15, 1994
Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy
I Tepler, G Schwartz, K Parker, et al.
The Journal of Infectious Diseases
|
December 1, 1978
The natural history of recurrent facial-oral infection with herpes simplex virus
C Bader, C S Crumpacker, L E Schnipper, et al.
Journal of Virology
|
May 1, 1973
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VI. Characterization of the DNA from five nondefective hybrid viruses
P H Henry, L E Schnipper, R J Samaha, et al.
Science (New York, N.Y.)
|
August 31, 1979
Vascular smooth muscle cell kinetics: a new assay for studying patterns of cellular proliferation in vivo
I D Goldberg, M B Stemerman, L E Schnipper, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1994
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age
K Antman, L Ayash, A Elias, et al.
Bone Marrow Transplantation
|
July 1, 1992
Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens
M V Seiden, A Elias, L Ayash, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1984
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir
S L Spruance, C S Crumpacker, L E Schnipper, et al.
Journal of Virology
|
December 1, 1976
Content and expression of integrated viral DNA in hamster cells transformed by nondefective adenovirus type 2- simian virus 40 hybrid viruses
J H Breeden, Y Wewerka-Lutz, L E Schnipper, et al.
Cancer Research
|
December 15, 1995
DNA topoisomerase II alpha expression is associated with alkylating agent resistance
J P Eder, V T Chan, S W Ng, et al.
Cancer Research
|
September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy
J P Eder, R C Bast, W P Peters, et al.
Page
of 6